Friday, June 26, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 795 of 1,261
  1. US 8822489

    Abuse deterrent compositions and methods of making same

    Acurx Pharmaceuticals, Inc. · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  2. US 8822470

    Substituted pyrido[2,3-b]pyrazines

    Takeda Pharmaceutical Company Limited · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  3. US 8822221

    Targeted integration into the PPP1R12C locus

    Sangamo Biosciences, Inc. · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  4. US 8822218

    Method of generating natural killer cells and dendritic cells from human embryonic stem cell-derived hemangioblasts

    Stem Cell & Regenerative Medicine International · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  5. US 8822467

    Biaryl oxyacetic acid compounds

    Ligand Pharmaceuticals Incorporated · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  6. US 8822461

    Oxabicycloheptanes and oxabicycloheptenes, their preparation and use

    Lixte Biotechnology, Inc. · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  7. US 8822434

    Compositions and methods to treat cardiac diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  8. US 8821943

    Methods and compositions for targeted delivery of therapeutic agents

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  9. US 8821922

    Compositions and methods for polymer-caged liposomes

    Northwestern University · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  10. US 8821930

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  11. US 8821899

    Method and process for the production of multi-coated recognitive and releasing systems

    The Board of Regents of the University of Texas System · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  12. US 8821896

    Purified Plasmodium and vaccine composition

    Sanaria Inc. · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  13. US 8821884

    Compositions and methods using MD-2 mutants and chimeric proteins

    The Regents of the University of California · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  14. US 8821880

    Methods and agents for the diagnosis and treatment of hepatocellular carcinoma

    China Synthetic Rubber Corporation · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  15. US 8821850

    Protein-polymer-drug conjugates

    Mersana Therapeutics, Inc. · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  16. US 8822522

    Dual-acting pyrazole antihypertensive agents

    Theravance Biopharma R&D IP, LLC · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  17. US 8822548

    Compounds with activity at estrogen receptors

    ACADIA Pharmaceuticals Inc. · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  18. US 8816058

    Polynucleotides encoding anti-CD100 antibodies or antigen-binding fragments thereof

    VACCINEX, INC. · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted
  19. US 8816151

    Stat5b transgenic mice and methods of use thereof

    Georgia Regents Research Institute, Inc. · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted
  20. US 8816091

    Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

    Theravance Biopharma R&D IP, LLC · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted
  21. US 8815845

    1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted
  22. US 8815229

    Granulysin in immunotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted
  23. US 8815917

    DP2 antagonist and uses thereof

    Panmira Pharmaceuticals, LLC · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted
  24. US 8816002

    Method involving 1-benzotriazolyl carbonate esters of poly(ethylene glycol)

    Nektar Therapeutics · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.